Clinical Pharmacist-led Inpatient Anticoagulation Stewardship Program

Atrial Fibrillation Clinical Trial

Official title: Implementation of Clinical Pharmacist-led Inpatient Anticoagulation Stewardship Program in An Egyptian Tertiary Care Hospital

Status Completed

Clinical Trial Summary

This study aims at evaluating the implementation of clinical-pharmacist-led anticoagulation stewardship program in Egyptian tertiary hospital to promote a culture of safety around anticoagulants.

Clinical Trial Description

One of the high-alert medication categories that may cause significant patient harm if not used correctly is anticoagulants. It is not clear if medication errors are more common with this category in specific compared to other medication categories, but the ramifications of a medication error with the use of anticoagulation agents is without a doubt detrimental to the patient's health and more serious than most of other drug categories.

This prospective study evaluates the impact of implementing an anticoagulation stewardship program, led by clinical pharmacists, on anticoagulation therapy outcomes during patient hospitalization by the percent of medication errors reduction, percent of adverse drug events reduction, and percent of evidence-based guidelines compliance improvement. ;

Related Conditions & MeSH terms

• Atrial Fibrillation
• Deep Vein Thrombosis
• Mitral Valve Disease
• Thrombosis
• Venous Thrombosis

• NCT number: NCT03812848
• Study type: Interventional
• Source: Ain Shams University
• Status: Completed
• Phase: N/A
• Start date: January 1, 2018
• Completion date: June 5, 2022